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ABSTRACT
Transcription termination of non-coding RNAs is reg-
ulated in yeast by a complex of three RNA binding
proteins: Nrd1, Nab3 and Sen1. Nrd1 is central in this
process by interacting with Rbp1 of RNA polymerase
II, Trf4 of TRAMP and GUAA/G terminator sequences.
We lack structural data for the last of these binding
events. We determined the structures of Nrd1 RNA
binding domain and its complexes with three GUAA-
containing RNAs, characterized RNA binding ener-
getics and tested rationally designed mutants in vivo.
The Nrd1 structure shows an RRM domain fused with
a second / domain that we name split domain
(SD), because it is formed by two non-consecutive
segments at each side of the RRM. The GUAA in-
teracts with both domains and with a pocket of wa-
ter molecules, trapped between the two stacking
adenines and the SD. Comprehensive binding stud-
ies demonstrate for the first time that Nrd1 has a
slight preference for GUAA over GUAG and genetic
and functional studies suggest that Nrd1 RNA bind-
ing domain might play further roles in non-coding
RNAs transcription termination.
INTRODUCTION
Genetic information is transcribed by three RNA poly-
merases in eukaryotes, specialised in different types of tran-
scripts. The RNA pol II transcribes the bulk of protein cod-
ing RNAs (mRNAs), some ‘classical’ non-coding genes of
well-known function (snoRNAs and snRNAs), and more
recently described non-coding transcripts of less known
function (i.e. CUTs, SUTs, etc.) (1). The biosynthesis of all
these transcripts is a tightly regulated process that is coor-
dinated with other events of RNA metabolism like nuclear
export and quality control/degradation. Transcription ter-
mination represents the final step and is performed through
two different pathways in budding yeast, dependent on
the nature of the transcript (for recent reviews, see (2–6)):
the cleavage and polyadenylation pathway, performed by
multiprotein factor CPF, processes the mRNAs by cleav-
ing the transcript in the 3′-UTR and adding a poly(A)
tail; and the Nrd1–Nab3–Sen1 pathway (NNS) deals with
the termination of functional non-coding RNAs (snoR-
NAs and snRNAs) (7) and promotes the degradation of
products arising from Pol II pervasive transcription (e.g.
CUTs) (8). This second pathway appears to be less con-
served along the eukaryote kingdom than the polyadeny-
lation one and involves three RNA-binding proteins (Nrd1,
Nab3 and Sen1) that couple RNA processing and degrada-
tion. Nab3 (9) and Nrd1 (10) have been extensively stud-
ied and contain RRM domains with sequence specificity
for UCUUG (7,11–13) and GUAA/G (10,12,13) respec-
tively. These elements are frequent in snoRNA termina-
tor sequences and their simultaneous recognition is surely
boosted by Nrd1-Nab3 heterodimerization (14). In addi-
tion, Nrd1 N-terminal CTD interaction domain (CID) in-
teracts specifically with phospho-Ser5 (pS5) repeats of C-
terminal domain (CTD) of RNA Pol II Rpb1 subunit
(15,16) and with Trf4 from TRAMP complex (17,18) us-
ing mutually exclusive interfaces. To further increase this
sophisticated landscape of interactions, Nab3 contains low
complexity regions and potential oligomerization domains
for autoassociation (19).
Currently, there are several structural studies that shed
light into this complex network of biomolecular interac-
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tions in the NNS complex. The NMR and X-ray struc-
tures of Nrd1 CID in complex with pS5 (16) and with Trf4
peptides (18) provide key insights into Nrd1 recruitment
to early elongation complexes and the incompatibility be-
tween this binding event and TRAMP recognition (thought
to occur later). The structure of Nrd1 CID-CTD (pS5) com-
plements those of Pcf11 CID-CTD(pS2) (20) and Rtt103
CID-CTD(pS2) (21) and gives mechanistic clues about how
these budding yeast Pol II CTD code readers are recruited
to the elongation complex at different stages. Conversely,
the protein-RNA recognition in NNS has been less stud-
ied at high-resolution. Complexes between Nab3 RRM and
UCUU have been solved by X-ray crystallography (22) and
NMR (23), but the recognition details of the higher affin-
ity sites (UCUUG) (11) remain unknown. The structure
of Nrd1 RNA binding domain has been studied by NMR
though only the fold for the RRM counterpart has been
determined. (24). In the same work, authors proposed that
Nrd1–RNA recognition is semi-specific.
Here, we report the X-ray and NMR structures of Nrd1
RBD. The structures show an unusual fold in which the
RRM-flanking sequences define a second well-folded /
domain (in contrast with previous data (24)). More im-
portantly, we present the X-ray structures of Nrd1 RBD
in complex with several RNA sequences containing the
GUAA motif, which reveal a unique binding mode that in-
volves both domains. These data, together with our ITC and
fluorescence anisotropy binding affinity studies, provide the
first explanation at atomic level for Nrd1 specific recogni-
tion of GUAA and GUAG previously seen both in vitro
(10,12,13) and in vivo (25,26). We use this detailed struc-
tural and biophysical information to rationally design a bat-
tery of mutants and study their changes in binding affinity,
growth defect phenotypes and snRN13 transcription termi-
nation defects in vivo. Our work provides high-resolution
key structure-function knowledge to progress in our un-
derstanding of the mechanism of transcription termination
through the NNS pathway.
MATERIALS AND METHODS
Cloning, protein expression and purification
Plasmids used in this work are summarised in Supplemen-
tary Table S1. Nrd1 sequences were amplified (KOD poly-
merase; Novagen) from Saccharomyces cerevisiae genomic
DNA and cloned in a pET28-modified vector containing
an N-terminal fusion cassette (thioredoxin A+6xHis+TEV
sequence) ((27) for details). Mutants were obtained with
a QuikChange Lightning Kit (Agilent genomics), both in
the pET28 and pRS415 plasmid backgrounds using specific
DNA oligos (IDT and Macrogen).
Samples of Nrd1 wild type and mutant proteins used
in structural and biophysical studies were produced by
overexpression in Escherichia coli BL21(DE3) cells (No-
vagen). Cultures were grown at 37◦C in LB with 30 g/l
of kanamycin (Sigma-Aldrich). Upon reaching OD600nm =
0.6–0.8, cells were transferred to 12◦C and induced with
0.5 M IPTG (Sigma-Aldrich) during 72–96 h. We noticed
that expression at higher temperatures result in production
of misfolded protein. Uniformly (15N and/or 13C) or selec-
tively unlabeled samples (see specific details in Supplemen-
tary Figure S1) were produced in a similar way in chemically
defined media ((27) for details). Selenomethionine substi-
tuted Nrd1301–489 was expressed similarly, just using minima
media supplemented with a mix of inhibition aminoacids
and Selenomethionine.
For protein purification, cell pellets were resuspended in
buffer A (25 mM Potassium Phosphate pH 8.0, 300 mM
NaCl, 10 mM imidazole, 5 mM -mercaptoethanol and 1
tablet/50 ml of protease inhibitors (Roche)), lysed by soni-
cation and cleared by ultracentrifugation. The supernatant
was filtered (0.22 m) and loaded in a HisTrap™ HP 5 ml
column (GE Healthcare), washed with buffer B (as buffer A
but with 500 mM NaCl and 30 mM Imidazole) and eluted
with buffer C (as buffer A but with 300 mM imidazole). The
samples were exchanged to buffer A and cleaved overnight
at 16◦C with homemade TEV protease (100 g/ml). Af-
ter complete cleavage, the sample was reloaded on the His-
Trap column, further washed with buffer A and selectively
eluted with buffer B (TEV protease, cleaved fusion and
traces of uncleaved product remain bound to the column).
Nrd1 samples were finally polished by gel filtration (Su-
perdex 200 preparative, GE Healthcare) equilibrated in 20
mM Tris–HCl pH 8, 200 mM NaCl and 0.1 mM DTT. Pu-
rified Nrd1 samples were concentrated and/or buffer ex-
changed according to their posterior use.
Protein crystallization
Crystallization experiments with Nrd1301–489 and
Nrd1290–468 constructs were performed at 291K using
the sitting-drop vapor-diffusion method and Hampton
Research and Quiagen commercial screens using 96-well
plates (Innovaplate SD-2 microplates, Innovadyne Tech-
nologies Inc). The crystallization conditions were scaled
up and refined in 24-well/48-well plates (Hampton Re-
search). Initially, Nrd1301–489 (23 mg ml−1) crystallized
in 15–18% (v/v) PEG 8000 and 0.1 M Bicine pH 9.3.
Selenomethionine (SeMet) modified Nrd1301–489 crystals
were obtained in very similar conditions consisting of 12%
(v/v) PEG 8000 and 0.1 M Bicine pH 9.0. Best condition
obtained for a shorter construct, Nrd1 290–468 (30 mg ml−1),
is 0.2 M potassium thiocyanate, 23% PEG 3350 (v/v).
A microseeding technique (28) was necessary to improve
the quality of these crystals. Apart from these conditions,
crystals were obtained in a variety of conditions including
a broad range of pHs and using a protein concentration
ranging from 20 to 30 mg ml−1. Nrd1 crystals appeared
from one to seven days after setting up the crystallization
trials.
We tried to prepare crystal complexes between Nrd1 and
RNAs with different lengths (4, 5, 6, 10 and 36 bases) by
co-crystallization or soaking using all variety of crystals
obtained. We had success only with soaking experiments
using crystals of Nrd1 290–468 (24 mg ml−1) grown in 1 M
sodium potassium phosphate pH 7.4. The RNA samples
were dissolved in the precipitant solution to a final con-
centration of 4 mM. Nrd1 290–468 complexes with GUAA,
CGUAAA and UUAGUAAUCC RNAs (IBA and IDT)
were obtained by slowly adding of 1 l of the RNA solu-
tion to the crystals drops followed by overnight (GUAA)
or three hours (CGUAAA and UUAGUAAUCC) incuba-
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tion. We only could obtain a single crystal in complex with
the longer RNA, since crystals were quickly crashed after
its addition. For complex with CGUAAA, Nrd1 290–468 was
dialyzed in 20 mM sodium potassium phosphate pH 8, 200
mM NaCl, 1 mM DTT buffer to remove the tris molecule
found in the structure.
Data collection and processing
Prior to data collection, all crystals were transferred for
a few seconds to the crystallization solution plus 20–25%
(v/v) ethylene glycol or 25%(v/v) glucose and then flash
cooled in liquid nitrogen. Diffraction data for Nrd1301–489
crystals were collected at the European Synchrotron Ra-
diation Facility (ESRF) (beamline ID23-1) (Grenoble,
France), while data sets for the SeMet Nrd1301–489 and Nrd1
290–468 (apo and soaked with RNA) were collected in ALBA
(beamline BL13-XALOC) synchrotron facilities at −173◦C
(Supplementary Table S2). Data processing was performed
with XDS package (29) and merging with Aimless (30) from
CCP4 suite (Collaborative Computational Project, Num-
ber 4, 1994). All constructs used crystallized in the tetrag-
onal space group P43212, whereas the shorter construct
Nrd1290–468 also crystallized in the hexagonal group P65, in
all cases with one molecule in the asymmetric unit (Supple-
mentary Table S2). The structure of Nrd1301–489 was solved
by single-wavelength anomalous dispersion (SAD) tech-
nique from the SeMet-Nrd1301–489 dataset collected at the
Se fluorescence peak wavelength. Two of three expected se-
lenium positions were located using SHELX (31). Bucca-
neer was used for preliminary model building (32). Subse-
quently the structure of non-substituted Nrd1301–489 was ob-
tained at 2.3 Å resolution by difference Fourier synthesis
using the experimental model above. The shorter construct
Nrd1290–468 hexagonal crystals diffracted to 1.6 Å resolu-
tion and its structure was obtained by molecular replace-
ment with MOLREP (33) using Nrd1 301–489 refined model
as a template. Finally, the Nrd1290–468 tetragonal crystals al-
lowed us to get three different RNA-Nrd1 complexes (Sup-
plementary Table S2), which diffracted to 2.45 Å maximum
resolution in the best case (GUAA complex). The structure
was solved by molecular replacement using the coordinates
of Nrd1290–468 as a search model. The RNAs were manu-
ally built into the electron density maps using COOT (34).
Model refinement in all cases was performed by alternat-
ing cycles of automatic refinement with REFMAC (35) and
manual building with COOT. Statistics for all data process-
ing and refinement are summarized in Supplementary Table
S2. The electron density maps allowed building of all chain
except for some N- and C-terminal residues (Supplemen-
tary Table S2). The stereochemistry has been checked with
PROCHECK (36). The figures of the models were gener-
ated with PYMOL (37).
NMR
Nrd1 samples (100–800 M) were prepared in NMR buffer
(25 mM Potassium Phosphate pH 6.5, 25 mM NaCl, 1 mM
DTT and 10% D2O) and experiments acquired at 25◦C
on cryoprobe-equipped Bruker AV800 MHz spectrometer.
Resonance assignments (1H, 15N and 13C) were obtained
with a battery of triple and double resonance 3D experi-
ments (HNCA, HNCO, CBCA(CO) NH, HCCH-TOCSY)
(38,39) that were processed with NMRPipe (40) and anal-
ysed with CcpNmr Analysis (41).
The Nrd1290–468 NMR structure was calculated from
NOE-derived distance restraints (Supplementary Tables
S3, S4 and Supplementary Figure S2) obtained from 2D
NOESY and 3D 13C/15N-HSQC-NOESY experiments and
from a set of 2D 13C–15N (F1-filtered) NOESY and 2D
13C–15N (F1/F2-doublefiltered) (42) NOESY experiments
recorded on samples with amino acid selective reverse un-
labeling (Supplementary Figures S1 and S2C). Backbone
dihedral angle restrains ( and  ) were obtained with TA-
LOS+ (43) from C, C, CO and NH chemical shifts. Struc-
tures were calculated with CYANA 2.1 (44), starting from
50 randomly-generated conformers, using a restrained sim-
ulated annealing protocol. The final 20 conformers with
lower target function and having no distance (>0.2 Å) and
angle (> 5◦) violations were selected and subjected to energy
minimization with AMBER
Nrd1290–468-GUAA complex formation was followed by
1H–15N-HSQCs by progressively adding the RNA (IBA),
in the same NMR buffer as free protein, until reach-
ing slight excess of (1:1.2). A series of 3D HNCO, 3D
HNCA and 3D CBCA(CO)HN were taken to assign Nrd1
bound state. The chemical shift perturbations (CPS) were
calculated for each NH peak with the equation: ∂av =
(1/2•((∂H)2+(0.2•∂N)2))1/2.
Fluorescence anisotropy
Measurements were performed in a BMG Polarstar Galaxy
plate reader essentially as described in (27). The tempera-
ture was 26◦C, the concentration of the fluorescein labeled
oligonucleotides (IDT) was 40 nM, and the buffer was 20
mM Tris–HCl, 150 mM NaCl, 1 mM DTT pH 8.0. A 1:1
binding model compatible with the experimental data was
fitted to the isotherms using BIOEQS software as previ-
ously described (27). Errors in the fitting parameters were
obtained by confidence limit testing, using the same soft-
ware, at the 67% confidence level. The intensity of the emis-
sion of the fluorescein dye remained essentially unchanged
in the presence of the protein.
Isothermal titration calorimetry
ITC experiments were performed at 25◦C using a Mi-
croCal iTC200 (Malvern Instruments, UK) calorimeter.
Protein and RNA samples were prepared in 20 mM
Potassium Phosphate buffer pH 7.0, 150 mM NaCl and
2 mM -mercaptoethanol. CCGUAACC (230 M) and
CCGUAGCC (470 M) RNAs (IDT) were titrated into
Nrd1290–468 at 24–25 and 46–48 M concentration, respec-
tively, placed in the 200 l sample cell. The reference cell was
filled with distilled water. Titration experiments consisted of
19 injections of 2 l (with a first injection of 0.4 l) sepa-
rated by 150 s to allow thermal power to return to baseline.
For homogeneous mixing in the cell, the stirring speed was
1000 rpm. Data were analysed with Origin 7.0 (OriginLab)
using a one-site binding model. The experiments were car-
ried out in duplicate. Control experiments of dilution of the
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RNAs into buffer were performed and the resulting heats
were subtracted from the protein-RNA titration data.
Yeast strains
Plasmids and strains used are listed in Supplementary Ta-
ble S1. Strains construction and other genetic manipula-
tions were performed following standard procedures (45).
Briefly, we used the EJS101-9d strain (10) to construct all
nrd1 mutants analysed in this study. In this strain, NRD1
has been replaced by the HIS3 marker, and a genomic wild-
type copy of NRD1 is expressed from a centromeric URA
plasmid (pRS316). We transformed EJS101–9d strain with
the centromeric LEU plasmid pRS415, containing either
wild-type (pRS415-NRD1) (15) or nrd1 mutant genes. Then,
the transformant were selected in –URA-LEU selective me-
dia, and thereafter grown in 5-FOA containing media, forc-
ing pRS316-NRD1 loss, and expression of NRD1 wt and
nrd1 mutant versions (obtained as described above) from
the LEU plasmid.
In the case of nrd1 mutations that caused lethality, we car-
ried out another approach to confirm it. We used then the
DLY883 strain (8), where NRD1 is expressed under the con-
trol of a GAL promoter. Thus, in glucose containing media,
NRD1 expression is abolished. We transformed DLY883
with an empty LEU plasmid (pRS415) or with the above
mentioned plasmids, bearing NRD1 wt or nrd1 gene mu-
tants. Yeast transformants were selected in 2% GAL–LEU
media and then transferred to a 4% glucose–LEU media to
turn off Nrd1 expression.
The EJS101-9d and DLY883 strains, as well as the
pRS415-NRD1 plasmid used as template to generate all
nrd1 mutated genes, were kindly provided by S. Buratowski.
Northern blot analysis
Total RNA was isolated using Qiagen Purification Kit from
cells grown at 28◦C and after a shift to 37◦C for 1 h. Approx-
imately 25 g of total RNA was loaded onto a 1.5% MOPS-
formaldehyde agarose gel, and then RNA was transferred
onto nylon membranes. Prehybridization and hybridization
were performed in a solution containing 1% SDS, 1 M NaCl
and 10% dextran sulphate at 60◦C. In the case of the prehy-
bridization, it was carried out for at least 2 h, and in the case
of the hybridization, the solution contained in addition the
radiolabeled probe (SNR13 or ADH1) and it was carried
out overnight. Thereafter, the membrane was twice washed
with 2× SSC, 1% SDS at 60◦C for 5 and 30 min, respectively
and once with 0.1× SSC for 1 h at room temperature. After
washes, the membranes were exposed to X-ray film.
RESULTS
Nrd1 RBD forms a novel structure with two domains
The sequence alignment along Nrd1 orthologues (Supple-
mentary Figure S3) shows high conservation in regions
flanking the canonical RRM domain (339–410). The 1H–
15N HSQC spectra of Nrd1301–489 and Nrd1290–468 con-
structs are very similar, with differences in the N- and C-
terminal regions (Supplementary Figure S4). The 13C con-
formational shifts (Supplementary Figure S5) revealed reg-
ular secondary structure elements (-sheets and -helices)
outside the RRM. In the Nrd1301–489 the C-terminal seg-
ment 468–489 is disordered (random coil 13C chemical shifts
and sharp linewidths; Supplementary Figures S4 and S5).
Given these observations we decided to setup crystalliza-
tion experiments with constructs including and lacking this
fragment.
Nrd1301–489 and Nrd1290–468 crystallized under different
conditions and two different space groups, P43212 and P65
(Supplementary Table S2). The structures of the two con-
structs are nearly identical with remarkable differences at
the N-terminus (before Asp308) and the C-terminus (af-
ter Ile463). The Nrd1 RBD adopts a dumbbell-like struc-
ture with two / domains occupying the positions of the
weights (Figure 1A). The RRM domain (residues 339 to
407) shows the classic / topology (Figure 1B). The sec-
ond domain is built up from two discontinuous segments
(304–338, 408–464) that flank the RRM (Figure 1A&B).
Topologically, its structure is accurately described as an in-
sertion of the RRM into one of the loops of this second
domain. For simplicity, we will refer to this second domain
as ‘split domain’ (SD). The SD architecture is different to
that of the RRM. It contains a mixed 5-stranded -sheet
with the two central strands in parallel orientation, and
an -helix that runs nearly perpendicular to the -sheet
(Figure 1B). Among the RRM structures having N- or C-
terminal extensions, the structure of the Nrd1 RBD repre-
sent an utterly new configuration. While we were preparing
this manuscript the structure of Seb1 RBD (Nrd1 homolog
in S. pombe) was published (46) showing an equivalent fold
to our Nrd1 structure.
The crystal structure of the Nrd1301–489 construct dis-
plays a longer C-terminus (464–471) than the structures of
the Nrd1290–468 construct (Supplementary Figure S6). These
residues fold back and loosely interact with the SD, in agree-
ment with their high temperature factors and sharp NMR
signals. The two crystal structures have different conforma-
tion at the N-terminus. In the Nrd1290–468 construct Leu305
interacts with Trp353 and the polypeptide chain can be
traced up to Asp302 (Supplementary Figure S6A) whereas
for the construct Nrd1301–489 the electron density is lost be-
fore His304 and Trp353 shows a flipped out conformation
(Supplementary Figure S6B).
We also obtained the NMR structure of Nrd1290–468 in
solution (Figure 1C and Supplementary Table S3) that is
essentially equivalent to the crystal one (Supplementary
Figure S7A) but reveals great differences from the pre-
viously published NMR structure (24), which shows an
RRM with very similar fold and an SD with no tertiary
fold (Supplementary Figure S7B). We think that this dis-
crepancy probably responds to differences in constructs
used or in protein expression protocols. The conformation
of the N-terminus (Supplementary Figure S6C) shows the
Leu305/Trp353 interaction seen in the crystal structure of
the equivalent construct (Supplementary Figure S6A), and
an additional contact with Phe298 (disordered in the crys-
tal). The Trp353 N1–H1 signal in the 1H–15N HSQC
spectrum of Nrd1290–468 is duplicated, a minor peak of 20%
population, evidencing conformational heterogeneity. The
position of this minor crosspeak coincides with the Trp353
N1-H1 peak in the Nrd1301–489 spectrum (Supplementary
Figure S4). Since this construct lacks Phe298, we interpret
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Figure 1. Structures of Nrd1 RNA binding domain. (A) Cartoon representation showing the RRM domain in pink and the SD in blue (different blue color
is used for fragments non consecutive in sequence). (B) Schematic representation of the protein topology showing the elements of secondary structure. (C)
Superposition of the NMR ensemble of the Nrd1290–468. (D) Scheme of interactions formed at the RRM–SD interface. Hydrogen bonds are shown in
dashed lines. (E) Structural detail around the Arg319 cluster. Residues are shown as sticks and colored in the same code as in A. Hydrogen bonds are
shown in dashed lines. (F) Structural detail around the Arg339 cluster. (G) Structural detail around the Arg384 cluster.
that the heterogeneity in the longer construct might arise
from slow exchange equilibrium of Phe298 coming in and
out of the Leu305/Trp353 site. This hypothesis is compati-
ble with the NOE data (Supplementary Figure S6D).
Altogether the X-ray and NMR data for Nrd1 RBD show
the coexistence of a well-folded two-domain core with N-
terminal and C-terminal tails that can interact loosely or in
multiple ways with it.
Nrd1 RRM and SD domains interact through a conserved po-
lar interface
The SD domain contains long loops with non-regular struc-
ture elements that interact with the upper loops of RRM
defining a large convex interface (Supplementary Figure
S8A). This intramolecular interface is predominantly polar
and maintained by an intricate network around three argi-
nine residues (Arg319, Arg339 and Arg384; Figure 1D–G).
On one side, Arg319 (partially exposed) forms a salt-bridge
with Glu386 and hydrogen bonds with backbone carbonyls
that freeze the orientation of the guanidium group (Fig-
ure 1E). At the most buried region of the interface, Arg339
coordinates an even more complex network of hydrogen
bonds/salt bridges with Glu459, Asp461 and Gln366 (Fig-
ure 1F). A second basic residue (Lys380) takes part on this
network and is probably important to keep this buried clus-
ter neutral. A layer of aromatics (Trp443, Tyr382, Tyr306
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and Trp353) separates the Arg339 and Arg319 clusters
(Supplementary Figure S8B). Finally, Arg384 (partially ex-
posed) closes the opposite end of the interface by a simi-
lar hydrogen bond network with backbone carbonyls of do-
main SD (Figure 1G). Despite its polar character, the SD–
RRM interface is dry; only two water molecules (with low
solvent accessibility and temperature factors) take part on
it (Supplementary Figure S8C).
Nrd1 recognizes GUAA specifically
RRM domains typically recognize RNA using exposed
residues in the -sheet (47–49), a potential interface that is
accessible in the structure of the Nrd1 RBD. Classical stud-
ies (10,12,13) and recent genome-wide CLIP maps (25,26)
proposed Nrd1 selectivity for the sequences GUAA and
GUAG. We have determined the binding affinities by ITC
and fluorescence anisotropy showing that Nrd1290–468 rec-
ognizes GUAA with slightly higher affinity than GUAG
and both of them with significantly larger affinity than the
AUAA, AUAU and AUUA probes (Figure 2 and Table
1). The relatively high affinity of the Nrd1:GUAA interac-
tion suggests that it might involve further residues than the
canonical ones in RRMs, because single RRMs typically
bind weaker than 2 M and without sequence specificity. To
unravel this issue we attempted to obtain the structures of
protein-RNA complexes by soaking and co-crystallization
with short RNAs. Only the soaking method, and using
tetragonal crystals from the Nrd1290–468 construct, was suc-
cessful and we obtained three complex structures of Nrd1
with GUAA, CGUAAA and UUAGUAAUCC RNAs
(Figure 3). The three sequences contain the GUAA motif,
found in the majority of transcripts processed through the
NNS pathway (12,25,26), and the last one derives from the
SNR13 terminator, one of the best characterized NNS tar-
gets (13). The core GUAA shows the same conformation in
the three Nrd1:RNA complexes and there was enough elec-
tron density to build extra bases for the longer RNAs (Fig-
ure 3C). However these additional bases have higher tem-
perature factors than the GUAA core and no evident con-
tacts with the protein, thus we reasoned that they are loosely
stabilized by intra RNA contacts. The Nrd1290–468:GUAA
crystal structure is consistent with NMR chemical shift per-
turbation data in solution, which map the RNA binding
pocket to the depression between RRM and SD domains
(Figure 3B). In conclusion, the structures suggest that Nrd1
RBD mainly recognises the core GUAA.
The Nrd1290–468:GUAA structure, with the highest res-
olution among the three complexes (Supplementary Table
S2), shows that both RRM and SD domains contribute to
GUAA recognition (Figure 3). The RNA interacts with the
RRM domain with its backbone running in the classical 5′
to 3′ orientation in all the RRM-RNA complexes reported
to date. A series of hydrogen bonds (G1 O2′-His376 N2,
U2 O2′-A3 OP1 and A3 O2′-A4 O5′) explain ribose speci-
ficity; in the case of U2, an unusual 2′-endo configuration
for the sugar puckering favors this ribose-specific recogni-
tion (Figure 3D,F). The RRM domain interacts with the
first three nucleotides: U2 (Figure 3F) and A3 (Figure 3G)
form archetypal planar stacking interactions with Phe342
and Phe378 respectively, whereas G1 stacks to the edge of
Phe342 ring (Figure 3E). SD Residues Ile369 and Tyr418
make additional stacking interactions with A3 and U2, re-
spectively. The fourth base (A4) forms a planar stacking
with A3 (Figure 3H), which together with Phe378 define a
three-layer aromatic array (Figure 3D&H). Residues from
SD (His303, Ile462 and Val464) make further contacts with
A4 (Figure 3H).
RNA base specificity is achieved by direct and water-
mediated hydrogen bonds to the protein. Positions 3 and
4 are specified by direct hydrogen bonds between the N6
positions of the adenines and the backbone carbonyls of
Val408 and Gly409 (Figure 3G and H). A4 N7 position
(purine over pyrimidine selectivity) is specifically recog-
nized by Arg413 and its mutation lowers affinity ∼10-
fold (Table 1), reinforcing the structural role of this con-
served residue (Supplementary Figure S3) in purine recog-
nition. A3 N7 position is recognized by a water molecule
that contacts simultaneously to U2 O2. The remaining
acceptors/donors of A3 and A4 are satisfied by interac-
tions with four water molecules that are trapped between
the RNA and the protein (Figure 3G and H). These wa-
ters are well structured, according to their temperature fac-
tors, but are not completely buried by the interaction; a
narrow channel on the back of this water pocket commu-
nicates it with the bulk solvent (Supplementary Figure S9).
U2 position is specified by the U2 N3-Trp406 O and by the
U2 O2-water hydrogen bonds (Figure 3F). The conserved
Tyr418 interacts with U2 and its mutation decreases RNA
affinity (Table 1). Finally, two hydrogen bonds (G1 N2-U2
OP1 and G1 N7-Gly345 NH) specify guanine at position
1 (Figure 3E). There is a third base-specific contact with a
Tris molecule (from the buffer) that bridges G1 with the
Arg403/Arg405 pair. The Nrd1290–468 crystal structure in
complex with CGUAAA, which was solved in phosphate
buffer (no Tris present), showed that only Arg403 makes
base-specific contacts (Arg403 N-G1 O6) (Supplementary
Figure S10). This result is consistent with mutational data
on the equivalent residue in Seb1 which lowers RNA affin-
ity dramatically (46). To enquire about the role of Arg405
in RNA recognition we measured energetics of binding of
the R405A mutant finding slightly higher affinity than for
wt protein (Table 1). Therefore, we confirm Arg403 as the
one involved in G1 O6 recognition. To further confirm the
guanine requirement at position 1, we tested substitution
by other purines. Substantial affinity losses were observed
upon inosine (∼15-fold: loss of N3 group) and adenine
(>40-fold: full remodeling of the Watson–Crick face) sub-
stitutions (Table 1 and Figure 2C).
Structural integrity of the RRM–SD tandem is key for RNA
recognition
RNA-binding causes little structural changes on Nrd1
(Supplementary Figure S11), suggesting that the RNA
binding site is structurally preconfigured. The X-ray struc-
tures of the different protein-RNA complexes reveal the key
elements for the RNA recognition. We made a thorough
mutagenesis analysis to gain insight into different contri-
butions to RNA binding energetics.
R374A, R413G and Y418A show a rather homoge-
neous decrease in affinity (15-fold KD increase) (Table 1),
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Figure 2. Biophysical analysis of RNA recognition by Nrd1 RBD. (A and B) Isothermal titration calorimetry thermograms (upper panels) and binding
isotherms (lower panels) obtained for titrations of CCGUAACC and CCGUAGCC RNAs over Nrd1290–468. Enthalpic and entropic contributions to
binding, KD (1/KB) and stoichiometry (N) are indicated on each curve. (C) Fluorescence anisotropy Nrd1290–468 titration curves over different RNAs (I =
ionosine). (D) Fluorescence anisotropy CCGUAACC titration curves over various Nrd1290–468 mutants. Fitted values are summarized in Table 1.
presumably due to loss of protein–RNA contacts (hydro-
gen bonds: R413G, hydrophobic: Y418A and columbic:
R374A). We also performed mutations in the second co-
ordination sphere (stabilizes residues in direct contact with
RNA): T340A, W437A and C415S/C416S, exhibiting more
modest effects (Table 1). Next we altered the RRM–SD in-
terface with different results: W353A mutant, that should
affect the interaction of the N-terminus with the RRM,
has a very little impact on GUAA recognition. In stark
contrast, K380A, at the heart of the RRM–SD interface,
lowers RNA affinity dramatically, likely due to a disrup-
tion of the interdomain arrangement. Finally, we mutated
the conserved residue Lys335 (Supplementary Figure S3),
placed at the centre of the SD -sheet and far away from
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Figure 3. X-ray structures of the Nrd1290–468:RNA complexes. (A) Nrd1290–468:GUAA complex represented as surface and colored by domains as in
Figure 1. The RNA is shown as sticks (C: yellow, O: red, N: blue and P: orange). (B) Nrd1290–468:GUAA complex in the same orientation as A and
with the surface colored by chemical shift mapping obtained for the same interaction by NMR (shades of red). (C) Nrd1290–468:CGUAAA (left) and
Nrd1290–468:UUAGUAAUCC (right) complexes. (D) Schematic representation of the Nrd1:GUAA interface. Hydrogen bonds are represented in dashed
lines. (E) Structural detail around G1. (F) Structural detail around U2. (G) Structural detail around A3. (H) Structural detail around A4. Water molecules
are shown as green spheres. Side-chains of residues interacting thought their backbone carbonyls or amide groups have been omitted for clarity.
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Table 1. Thermodynamic parameters of wt and mutants Nrd1290–468/RNA interactions determined by isothermal titration calorimetry (ITC) and fluo-
rescence anisotropy (FA)
Exp. Protein Mutant RNAa G (kcal/mol)b KD (M)c
ITC Nrd1 wt CCGUAACC 7.74 ± 0.05 2.1 ± 0.1
ITC Nrd1 wt CCGUAGCC 6.95 ± 0.08 8 ± 1
FA txA-Nrd1 wt CCGUAACC 8.0 ± 0.1 1.4 ± 0.2
FA txA-Nrd1 wt CCGUAGCC 7.2 ± 0.2 5 ± 1
FA txA-Nrd1 wt CCCAUAACCC n.d. ∼50d
FA txA-Nrd1 wt CCCIUAACCC 6.5 ±. 0.2 18 ± 5
FA txA-Nrd1 wt CCCAUUACCC n.d. ∼160d
FA txA-Nrd1 wt CCCAUAUCCC n.d. ∼110d
FA txA-Nrd1 K335E CCGUAACC 6.8 ± 0.1 11 ±1
FA txA-Nrd1 K335M CCGUAACC 8.1 ± 0.1 1.2 ±0.2
FA txA-Nrd1 K335R CCGUAACC 7.9 ± 0.2 1.7 ±0.4
FA txA-Nrd1 T340A CCGUAACC 6.9 ± 0.2 9 ± 2
FA txA-Nrd1 W353A CCGUAACC 7.8 ± 0.1 2.0 ± 0.3
FA txA-Nrd1 R374A CCGUAACC 6.5 ± 0.2 18 ± 5
FA txA-Nrd1 K380A CCGUAACC n.d. ∼135d
FA txA-Nrd1 R405A CCGUAACC 8.8 ± 0.1 0.37±0.05
FA txA-Nrd1 R413G CCGUAACC 6.4 ± 0.2 21 ± 6
FA txA-Nrd1 C415S/C416S CCGUAACC 7.2 ± 0.2 5 ± 1
FA txA-Nrd1 Y418A CCGUAACC 6.4 ± 0.1 21 ± 3
FA txA-Nrd1 W437A CCGUAACC 7.3 ± 0.2 5 ± 1
aSequences 5′- to 3′. All RNAs used for fluorescence anisotropy were fluorescein-labeled at 5′. I = inosine.
bDissociation G obtained in FA from non-linear least squares fitting of the data. ITC values and uncertainties were calculated from G = RT•ln(KB,obs)
and error propagation.
cKD = (KB,obs)-1 in ITC. Apparent KD values and uncertainties in FA were calculated from KD = e(–G/RT) and error propagation.
dEstimations assuming similar fluorescence anisotropy changes as those obtained in the curves in which saturation was reached.
n.d.: not determined due to insufficient saturation.
the RNA-binding site (Supplementary Figure S11). This is
not involved in RNA recognition, however the K335E ex-
hibits a small GUAA affinity loss (Table 1). Lys335 forms a
conserved salt bridge with Asp326, thus we argue that the
K335E mutant might introduce a destabilizing repulsion ef-
fect. To prove this, we measured RNA binding affinity of
more structurally compatible K335R and K335M mutants,
which rendered values indistinguishable from wt.
Altogether, we conclude that the SD plays a scaffolding
role allowing the structural preconfiguration of the GUAA
binding site in Nrd1.
The split domain of Nrd1 is essential for viability
Genomic removal of Nrd1 compromises cell viability (10).
We aimed to find out if the Nrd1 SD (Figure 4A) affects
cell survival by introducing LEU plasmids containing wild-
type NRD1 (wt), complete SD deletion (301–336/412–
463) or partial deletions (SDA = 301–336 and SDB
= 412–463) of this domain in a yeast strain harbouring
a centromeric URA plasmid expressing a genomic copy of
NRD1 (10). Loss of the URA wild-type plasmid upon 5-
FOA treatment and plasmid shuffling results in cell lethal-
ity in all the SD deletion: only the cells bearing wt NRD1
remain viable (Figure 4B left panel). We further tested syn-
thetic lethality of these SD deletion mutants using another
method: controlling genomic wt NRD1 expression under
the GAL promoter. As shown, cells harboring SD deletion
mutations are unable to grow in glucose containing media
(Figure 4B, right panel). Therefore, the SD is a key element
for Nrd1 activity due to either its role in specific recognition
of RNA terminators (as described in our Nrd1:RNA struc-
tures) or to other unknown functions. We extended our mu-
tagenesis study to delve deeper into these important ques-
tions.
Nrd1 has a conserved sequence at the C-terminus
(residues 551–575) (Supplementary Figure S12), which in-
cludes a polyglutamine tail. We introduced stop codon
mutations at several positions after the RBD (L558stop,
Q567stop and K490stop) that do not cause cell growth de-
fects (Figure 4C), suggesting that the conserved Nrd1 C-
terminus is not critical for its function. In contrast, dis-
rupting Nrd1 from the Val468 residue (V468stop) provokes
significant growth defects at all tested temperatures (Fig-
ure 4C, upper panel). The nrd1Δ301–306 mutant, at the
N-terminus of the RBD, shows less marked growth defects
(Figure 4C, bottom panel).
Next we explored how changes in RNA affinity affect
Nrd1 function in vivo. In general, mutations causing mi-
nor affinity losses (W353A, C415S/C416S, W437A) do
not display noticeable growth defects. Although in the
R374A, R413G and Y418A mutants, affecting direct Nrd1–
RNA contacts and displaying similar KD increases (Table
1), only Y418A cells present slow growth at 37◦C (Fig-
ure 4C, bottom panel). Conversely, K335E, with less im-
pact in RNA recognition, has a strong growth defect,
which is comparable with the previously reported defects
on T340A and K380A (24) (Figure 4C). More importantly,
Y418A/K335E double mutation (with both residues be-
longing to the SD) causes an extraordinary slow growth at
28◦C and lethality at 37◦C (Figure 4C). Therefore, this dou-
ble mutation is almost as aggressive as the SD deletion mu-
tants (Figure 4B). The growth defect caused by the K335E
is not totally rescued in the case of K335M and K335R
(Figure 4C). These two mutants show RNA binding affini-
ties indistinguishable from that of wt (Table 1), therefore we
10302 Nucleic Acids Research, 2017, Vol. 45, No. 17
Figure 4. Nrd1 RBD functional analysis. (A) Schematic representation of Nrd1 domain organization. (B) Partial or total deletion of the Nrd1-SD causes
cell lethality. Left panel, the indicated strains were grown in -LEU-URA selective media and then replicated onto 5-FOA containing media and grown for
2–3 days at 28◦C. Right panel, strains with the indicated genotypes were grown in galactose (GAL) or glucose (GLU) containing media and grown for 2–3
days. (C) Analysis of nrd1 mutants growth phenotypes. Serial dilutions (1:10) of wt and nrd1 mutant strains were spotted on selective SC media and grown
for 2–3 days at the indicated temperatures. (D) Northern blot analyses of the SNR13 and ADH1 genes. Total RNA was purified from the indicated strains
grown at 28◦C and 37◦C. In addition, wt and sen1–1 isogenic strains were used as positive control for transcription termination defects (50). Full-length
snR13 and readthrough transcripts are indicated by arrows. A schematic representation of SNR13 gene and 3′ end flanking region is also shown, where
the size and localization of the probe is represented by a black bar above SNR13 coding region.
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propose that they alter some functions of Nrd1 RBD not
related to their RNA binding; probably unknown protein-
protein interactions with other components of the NNS
pathway.
Finally we decided to test whether the mutants exhibit-
ing reduced cell growth phenotypes also showed transcrip-
tion termination defects at both 28◦C and 37◦C. For that
purpose, we analysed the well-known SNR13 transcript by
northern blot assay as described in (50). We used as a posi-
tive control of snoRNA transcription termination defects
the sen1–1 mutant grown at 37◦C (50). SNR13 displayed
strong transcription termination defects at 28◦C and 37◦C
in nrd1Δ301–306 mutant, and to a lesser extent, but sig-
nificantly, in nrd1-K335E cells at 37◦C, consistent with the
extraordinary reduced growth of that mutant at this tem-
perature. In the case of nrd1-T340A cells, whose mutation
lies into the RRM domain, SNR13 transcription termina-
tion defects are also observed at both temperatures (Figure
4D). Therefore, these data suggest that both RRM and SD
have a role in snoRNAs transcription termination. The fact
that K335E and T340A mutants do not show a very marked
RNA affinity lost (Table 1) lead us to think the biological
role of Nrd1 RBD in snoRNAs transcription termination
might not be solely dependent on RNA binding.
DISCUSSION
Widely found in eukaryotes, the RRMs have a typical archi-
tecture (1−1−2−3−2−4) in which the RNA recog-
nition residues (RNP1 and RNP2 motifs) are on the ex-
posed face of 2 and 3 (47–49,51,52). From this basic
fold, there are a number of RRMs with extended features,
typically built from additional regions on the C- and/or
N-termini: extra -strands (53), -helices (54–56) and -
sheets (27). The structure of Nrd1 RBD is a new class of
RRM; it contains additional N- and C-terminal extensions
which, rather than adding extra secondary structural el-
ements, form together a domain by itself (SD). The SD
is fused to the RRM through an intricate polar interface,
defining a rigid body structure. The structures of Nrd1
and Seb1 (46) RBDs have similar folds, differing in that
Nrd1 RBD includes long N-terminal extensions that make
further contacts with the RRM domain (Supplementary
Figure S13 A&B). The RRM–SD interface is mostly con-
served between Nrd1 and Seb1 RBDs (Supplementary Fig-
ure S13C–E). Only the Arg319 cluster is not present in
Seb1 and the rest of RRM–SD interfacial residues: Arg339,
Lys380, Arg384, Gln366, Trp406, Pro460 and Asp461, are
totally conserved in fungi (Supplementary Figure S3), sug-
gesting a conservation of the Nrd1/Seb1 RBD structure at
least in yeast and moulds.
Seb1 RBD binds AUUAGUAAAA with 1.8 M affinity
(46), a remarkably close value to the 1.5–2.1 M affinity
that we measured for Nrd1 RBD binding to CCGUAACC.
Both Seb1 and Nrd1 RNA targets contain the GUAA mo-
tif. These similarities suggest that Seb1 might have a simi-
lar RNA binding mode than Nrd1, hence we constructed
a model of the Seb1:RNA complex by placing the RNA
on the Seb1 structure in the same conformation as in the
Nrd1290–468:GUAA complex (Supplementary Figure S13F).
This simple model is likely realistic because, as it happens
for Nrd1 (Supplementary Figure S11), we expect little con-
formational changes in Seb1 upon binding. In support of
this model, the mutagenesis data (46) show that the biggest
changes in RNA binding affinity affect interfacial residues,
while other mutants, far from the hypothetical binding site,
cause negligible effects. In conclusion, we predict that Seb1
will bind RNAs with the GUAA/G motif by using a similar
mode as Nrd1 RBD, which is probably conserved across the
family with minor variations.
Both GUAA and GUAG sequences have been identified
at NNS terminator regions (10,12,13). Nrd1 binds GUAG
terminators with four times lower affinity than for GUAA
ones. In both cases binding is enthalpically driven (Figure 2)
in agreement with the formation of multiple polar interac-
tions: hydrogen bonds and salt bridges. However, the mag-
nitude of H is lower for the GUAG complex (Figure 2)
suggesting that there are less polar contacts in this case. In
the Nrd1:GUAA complex, A4 acts as a sort of molecular
gate trapping four water molecules between the RNA and
the SD (Figure 3G). We hypothesize that a suboptimal bind-
ing of G4 would facilitate the release of these ligand-binding
waters providing an explanation for the loss in H contri-
bution in GUAG complex formation with respect to that of
GUAA one.
The uniqueness of Nrd1-like RBD structure opens the
question of whether this domain might play further roles
beyond RNA binding. We demonstrated that the SD ac-
companying the canonical RRM is important for cell via-
bility (Figure 4B) and its role in RNA binding is demon-
strated by structural and mutagenesis data. SD mutants
nrd1-K335E and nrd1(301–306) exhibit both cell growth
and SNR13 termination defects (Figure 4C and D). In the
case of Lys335, a conserved residue in the opposite face
of the RNA binding pocket, its mutation might slightly
perturb the SD stability/architecture but not sufficiently
to cause a dramatic change in RNA binding affinity (Ta-
ble 1). Instead the nrd1-K335E phenotype is likely due to
the disruption of other interactions within the NNS path-
way. Currently, we have sufficient structural/biochemical
information to designate potential targets for Nrd1 RBD
protein–protein interactions. The two known Nrd1 anchor-
ing points to the RNA pol II are the nascent RNA and
the pS5 Rpb1 CTD repeats, both facing toward the same
side of the enzyme (Supplementary Figure S14). Nrd1 in-
teracts with Nab3 through its heterodimerization domain
(14) and both co-purify with the RNA helicase Sen1 (57).
However, Sen1 recruitment to the NNS complex seems to be
mediated by Nab3, rather than by Nrd1 (58). On the other
hand, the RNA Pol II stalk, formed by the Rpb4/Rbp7
heterodimer, participates in the recruitment of RNA pro-
cessing factors and CTD modifying enzymes (59–61). In-
terestingly, nascent RNA exits making contacts with Rpb7
(62) and Nrd1 interacts physically with Rpb7 through its C-
terminus (including half of the SD) (63). The temperature
sensitive phenotype of nrd1-V468stop might be due to a par-
tial or total disruption of this interaction. If so, the Nrd1-
Rpb7 interaction would locate the Nrd1 RBD on the direct
exit route of the newly synthetized RNA, allowing an early
recognition of GUAA/G sequences, which perhaps triggers
transcription termination.
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ACCESSION NUMBERS
Atomic coordinates of the protein structures and their com-
plexes have been deposited in the Protein Data Bank (PDB)
with the following accession codes: 5O1W (crystal structure
of Nrd1301–489); 5O1X (crystal structure of Nrd1290–468);
5O1Y (crystal structure of Nrd1290–468 in complex with
GUAA RNA); 5O1Z (crystal structure of Nrd1290–468 in
complex with CGUAAA RNA); 5O20 (crystal structure of
Nrd1290–468 in complex with UUAGUAAUCC RNA (corre-
sponds to SNR13 148–157)) and 5O1T (Nrd1290–468 NMR
structure). The chemical shifts for Nrd1290–468 construct has
been deposited on the Biological Magnetic Resonance Bank
(BMRB) with the accession code 34140.
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